Loading…
Urinary and Biliary Metabolites of Genistein in Rats
Examination was made of the urinary and biliary excretion of the metabolites of genistein and genistin, the major components of Glycine and Sophora genus in rats. The urine of rats administered genistein orally contained eight metabolites. Three of these metabolites, genistein 4'-O-sulfate (M-1...
Saved in:
Published in: | Biological & pharmaceutical bulletin 1996/03/15, Vol.19(3), pp.413-417 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Examination was made of the urinary and biliary excretion of the metabolites of genistein and genistin, the major components of Glycine and Sophora genus in rats. The urine of rats administered genistein orally contained eight metabolites. Three of these metabolites, genistein 4'-O-sulfate (M-1), genistein 7-O-β-D-glucuronide (M-3), genistein 4'-O-sulfate 7-O-β-D-glucuronide (M-6), were identified from spectroscopic and chemical data. The bile of rats administered genistein orally contained M-2, M-3 and M-6. M-6, a major biliary metabolite, was isolated and identified from spectroscopic and chemical data. The urine or bile of rats treated with genistin, the glycoside of genistein, contained M-1-M-8 or M-2, M-3, M-6 in the above metabolites. These findings suggest that genistin is absorbed as genistein after hydrolysis in the gastrointestinal tract. The total cumulative amounts of the two metabolites and genistein excreted in the urine during 48h, or of M-6 excreted in the bile during 36h following the oral administration of genistein, were approximately 5.7% or 16.0% of the doses administered, respectively. The results show that M-1, M-3 and M-6, having a free hydroxyl, glucuronide-or sulfate-conjugated hydroxyls at the C-7 or C-4' position, are excreted in the urine and bile as parts of the metabolites of genistein. |
---|---|
ISSN: | 0918-6158 1347-5215 |
DOI: | 10.1248/bpb.19.413 |